![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new treatment options. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader. Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new treatment options. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
Patients were treated in the dose-escalation portion of the Phase 1/2 study evaluating seclidemstat in combination with azacitidine Investigators reported a 43% overall response rate among 14...
HOUSTON, June 12, 2024 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop...
Patient Enrollment Resumed in the Investigator-initiated Phase 1/2 Clinical Trial of Seclidemstat in Combination with Azacitidine to Treat Hematologic Cancers Company Implemented Significant...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.17 | -7.14285714286 | 2.38 | 2.94 | 2.03 | 56668 | 2.68013521 | CS |
4 | 1.766 | 397.747747748 | 0.444 | 3.88 | 0.3868 | 75320 | 2.30006475 | CS |
12 | 1.6994 | 332.824128476 | 0.5106 | 3.88 | 0.3868 | 44075 | 1.42088414 | CS |
26 | 1.58 | 250.793650794 | 0.63 | 3.88 | 0.3868 | 79163 | 0.76329952 | CS |
52 | 0.71 | 47.3333333333 | 1.5 | 3.88 | 0.3868 | 65500 | 0.77568295 | CS |
156 | -22.2875 | -90.978671293 | 24.4975 | 30 | 0.3868 | 372851 | 12.18743834 | CS |
260 | -286.54 | -99.2346320346 | 288.75 | 370.385 | 0.3868 | 552256 | 28.5145196 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions